[Special Nature/Scientific American 2014 issue] Cancer: The March on Malignancy
This 2014 issue of Nature (in collaboration with Scientific American) is free to read by all.
Tailoring cancer treatment to individual and evolving tumours is the way of the future, but scientists are still hashing out the details
Effective treatment of cancer requires getting the drugs precisely to the target. Enter the nanoparticle
- Comparative Biology
A subterranean species that seems to be cancer-proof is providing promising clues on how we might prevent the disease in humans
- Developing World
Much of the world is ill-equipped to cope with its rising cancer burden and are pushing prevention and screening
Carcinogens are all around us, so scientists are broadening their ideas of environmental risk
Despite a huge amount of funding and research, regional and individual differences in cancer trends make it a hard disease to wipe out
Grouping patients according to their molecular profile can make for better and faster drug approval decisions
The torrents of data flowing out of cancer research and treatment are yielding fresh insight into the disease
Genomics can provide powerful tools against cancer — but only once clinical information can be made broadly available
Even as cancer therapies improve, basic questions about drug resistance, tumour spread and the role of normal tissue remain unanswered
No comments yet.